Observational Study
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results

World J Virol
6(4):59-72.
Published online Nov 12, 2017.
doi: 10.5501/wjv.v6.i4.59
Abstract (1765)
|
Core Tip (1388)
|
Full Article (HTML) (4941)
|
Figures (1-2) (338)
|
Tables (1-8) (581)
|
Full Article (PDF)-3636K (712)
|
Audio-1488K (45)
|
Peer-Review Report-117K (324)
|
Answering Reviewers-157K (314)
|
Supplementary Material-128K (353)
|
Received: 06/11/2017
|
Revised: 08/03/2017
|
Accepted: 09/17/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (22335)
|
Similar Articles (16)
|
Timeline of Article Publication (6)
|
Authors Evaluation (12)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open